Immune Escape by Non-coding RNAs of the Epstein Barr Virus
Epstein Barr virus (EBV) is one of the most successful pathogens of humans, persistently colonizing more than 95% of the adult human population. At the same time EBV encodes oncogenes that can readily transform human B cells in culture and threaten healthy virus carriers with lymphomagenesis. Cytoto...
Main Author: | Christian Münz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.657387/full |
Similar Items
-
Unconventional Peptide Presentation by Classical MHC Class I and Implications for T and NK Cell Activation
by: Dirk M. Zajonc
Published: (2020-10-01) -
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
by: Anita Murer, et al.
Published: (2019-01-01) -
Redirecting T Cells against Epstein–Barr Virus Infection and Associated Oncogenesis
by: Christian Münz
Published: (2020-06-01) -
Roles of Lytic Viral Replication and Co-Infections in the Oncogenesis and Immune Control of the Epstein–Barr Virus
by: Yun Deng, et al.
Published: (2021-05-01) -
The role of insulin-regulated aminopeptidase in MHC class I antigen presentation
by: Peter M Van Endert, et al.
Published: (2012-03-01)